Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Uromodulin-like 1 (UMODL1), also known as olfactorin, is a calcium-dependent membrane-bound extracellular matrix protein carrying EGF-like, WAP, and FNIII domains[2][3][4]. It is expressed during the development of the olfactory system and along the migratory route of hypothalamic gonadotropin-releasing hormone (GnRH) neurons[2][4]. UMODL1 shares functional and structural similarity with anosmin-1 and is implicated in axonal guidance, neuronal migration, and proper connectivity of GnRH and olfactory neurons. Its deficiency in animal models leads to abnormal development of these neurons, reproductive defects, and altered immune response[2][3][4]. Location on chromosome 21 suggests potential linkage to Down syndrome phenotypes, though its precise disease mechanisms in humans remain under study[2]. UMODL1 is under experimental investigation as a candidate gene in Kallmann syndrome, with no approved drugs targeting it and unknown baseline safety profiles for clinical exploitation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uromodulin-like 1 (UMODL1).